# Omega 3 Mood Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/omega-3-mood-randomized-trial-evidence-review
Category: evidence-review
Summary: Omega 3 Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomize
Last reviewed: 2026-06-25
Reviewed by: Migaku Evidence Review
# Omega 3 Mood Randomized Trial: What the Evidence Says

## Quick Answer

Omega 3 Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of omega-3 PUFA-enriched egg consumption on metabolic parameters in elderly adults with metabolic syndrome: study protocol for a randomized controlled trial | randomized trial | 2 | 2026-05-19 | 10.3389/fnut.2026.1831128 |
| From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression. | research article | 4 | 2026-04-22 | 10.3390/nu18091318 |

## What The Sources Report

- Metabolic syndrome (MetS), one of the most prevalent chronic disorders worldwide, is a clinical entity characterized by central obesity, hypertension, dysglycemia, elevated triglycerides, and reduced high-density lipoprotein cholesterol. [Yang Haiyue (2026); evidence level 2]
- The prevalence of metabolic syndrome (MetS) remains high among community-dwelling older adults aged 65 years and older, and is associated with elevated risks of cardiovascular disease, type 2 diabetes mellitus, and physical functional decline. [Yang Haiyue (2026); evidence level 2]
- Mechanistic evidence implicates neuroimmune activation, inflammation, altered neurotransmitter synthesis, and microbiota-derived metabolites. [Hachmeriyan A (2026); evidence level 4]
- Objective: The objective of this study is to synthesize evidence on omega-3 polyunsaturated fatty acids ( n -3 PUFAs), the microbiota-gut-brain axis, and vitamins and minerals that influence neurotransmitter synthesis, inflammation, and brain function and to translate these findings into food-based strategies. [Hachmeriyan A (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For omega 3 mood randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Yang Haiyue (2026). Effects of omega-3 PUFA-enriched egg consumption on metabolic parameters in elderly adults with metabolic syndrome: study protocol for a randomized controlled trial. DOI: 10.3389/fnut.2026.1831128. PMCID: PMC13226538. PMID: 42239715. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13226538/
- Hachmeriyan A (2026). From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression.. DOI: 10.3390/nu18091318. PMCID: PMC13165168. PMID: 42123920. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165168/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.